Home > Balance Sheet > BLISS GVS PHARMA

BLISS GVS PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
BLISS GVS PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹37 Cr₹51 Cr₹43 Cr₹29 Cr₹45 Cr

What is the latest Total Non-Current Liabilities ratio of BLISS GVS PHARMA ?

The latest Total Non-Current Liabilities ratio of BLISS GVS PHARMA is ₹37 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹37 Cr
Mar2024₹51 Cr
Mar2023₹43 Cr
Mar2022₹29 Cr
Mar2021₹45 Cr

How is Total Non-Current Liabilities of BLISS GVS PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹37 Cr
-27.20
Mar2024 ₹51 Cr
19.52
Mar2023 ₹43 Cr
46.71
Mar2022 ₹29 Cr
-35.46
Mar2021 ₹45 Cr -

Compare Total Non-Current Liabilities of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹4,648.2 Cr 4.5% 56.5% 219.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,620.0 Cr 1% -0.9% 6.8% Stock Analytics
DIVIS LABORATORIES ₹176,087.0 Cr 1.8% -2.3% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹154,837.0 Cr 3.7% 6.5% 44.9% Stock Analytics
CIPLA ₹112,194.0 Cr 0% 4.7% -8% Stock Analytics
DR REDDYS LABORATORIES ₹106,328.0 Cr -0.2% 0.7% -3.4% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

4.5%

56.5%

219.5%

SENSEX

1.7%

1.3%

-7.3%


You may also like the below Video Courses